Experimental parkinsonism modulates multiple genes involved in the transduction of dopaminergic signals in the striatum

Neurobiology of Disease

Volumn 10, Issue 3, 2002, Pages 387-395

  Napolitano, Maddalena ^a   Centonze, Diego ^b,c   Calce, Angelica ^d   Picconi, Barbara ^b,c   Spiezia, Stefania ^a   Gulino, Alberto ^a   Bernardi, Giorgio ^b,c   Calabresi, Paolo ^b,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^d IRCCS NEUROMED   (Italy)

Author keywords

6 hydroxydopamine; Basal ganglia; cDNA microarrays; Glutamate transmission; Parkinson's disease; Synaptic plasticity

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR; ADENOSINE TRIPHOSPHATASE (CALCIUM); AMPHIPHYSIN; BETA ARRESTIN; CASEIN KINASE I; CASEIN KINASE II; CHROMOGRANIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN DEPENDENT KINASE 5; CYCLINE; CYTOCHROME C OXIDASE; ELONGATION FACTOR 3; GASTRIC INHIBITORY POLYPEPTIDE; GLUTAMIC ACID; HEAT SHOCK PROTEIN 90; ISOPROTEIN; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; NERVE GROWTH FACTOR; NEUROMODULIN; OXIDOPAMINE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE C; PROTHYMOSIN ALPHA; RAS PROTEIN; RETINOID X RECEPTOR; SOMATOMEDIN BINDING PROTEIN; SYNAPSIN I; SYNTAXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; CORPUS STRIATUM; DENERVATION; DNA MICROARRAY; DOPAMINERGIC SYSTEM; GENE EXPRESSION; GENETIC ANALYSIS; MALE; MUTATION; NEUROTRANSMISSION; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION;

EID: 0036408413     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2002.0525     Document Type: Article

References (46)

1. Barone, P., Morelli, M., Popoli, M., Cicarelli, G., Campanella, G., & Di Chiara, G. (1994) Behavioural sensitization in 6-hydroxydopamine lesioned rats involves the dopamine signal transduction: Changes in DARPP-32 phosphorylation. Neuroscience 61, 867-873.
2. Bibb, J. A., Snyder, G. L., Nishi, A., Yan, Z., Meijer, L., Fienberg, A. A., Tsai, L. H., Kwon, Y. T., Girault, J. A., Czernik, A. J., Huganir, R. L., Hemmings, H. C., Jr, Nairn, A. C., & Greengard P. (1999) Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature 402, 669-671.
3. Braun, A. R., & Chase, T. N. (1986) Obligatory D1/D2 receptor interaction in the generation of dopamine agonist-related behaviors. Eur. J. Pharmacol. 131, 301-306.
4. Calabresi, P., Maj, R., Pisani, A., Mercuri, N. B., & Bernardi, G. (1992a) Long-term depression in the striatum: Physiological and pharmacological characterization. J. Neurosci. 12, 4224-4233
5. Calabresi, P., Maj, R., Mercuri, N. B., & Bernardi, G. (1992b) Coactivation of D1 and D2 dopamine receptors is required for long-term synaptic depression in the striatum. Neurosci. Lett. 142, 95-99
6. Calabresi, P., Mercuri, N. B., Sancesario, G., & Bernardi, G. (1993) Electrophysiology of dopamine-denervated striatal neurons: Implications for Parkinson's disease. Brain 116, 433-452.
7. Calabresi, P., Centonze, D., & Bernardi, G. (2000) Electrophysiology of dopamine in normal and denervated striatal neurons. Trends Neurosci. 23(Suppl.), S57-S63.
8. Centonze, D., Gubellini, P., Picconi, B., Calabresi, P., Giacomini, P., & Bernardi, G. (1999a) Unilateral dopamine denervation blocks corticostriatal LTP. J. Neurophysiol. 82, 3575-3579.
9. Centonze, D., Calabresi, P., Giacomini, P., & Bernardi, G. (1999b) Neurophysiology of Parkinson's disease: From basic research to clinical correlates. Clin. Neurophysiol. 110, 2006-2013.
10. Chase, T. N., Oh, J. D., & Blanchet, P. J. (1998) Neostriatal mechanisms in Parkinson's disease. Neurology 51(Suppl. 2), S30-S35.
11. Desdouits, F., Siciliano, J. C., Greengard, P., & Girault, J. A. (1995) Dopamine- and cAMP-regulated phosphoprotein DARPP-32: Phosphorylation of Ser-137 by casein kinase I inhibits dephosphorylation of Thr-34 by calcineurin. Proc. Natl. Acad. Sci. USA 92, 2682-2685.
12. Dunah, A. W., Wang, Y., Yasuda, R. P., Kamayama, K., Huganir, R. L., Wolfe, B. B., & Standaert, D. G. (2000) Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease. Mol. Pharmacol. 57, 342-352.
13. Fernandez, A., Brautigan, D. L., Mumby, M., & Lamb, N. J. (1990) Protein phosphatase type-1, not type-2A, modulates actin microfilament integrity and myosin light chain phosphorylation in living nonmuscle cells. J. Cell Biol. 111, 103-112.
14. Girault, J. A., Hemmings, H. C., Jr, Williams, K. R., Nairn, A. C., & Greengard, P. (1989a) Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase II. J. Biol. Chem. 264, 21747-21759.
15. Girault, J. A., Raisman-Vozari, R., Agid, Y., & Greengard, P. (1989b) Striatal phosphoproteins in Parkinson disease and progressive supranuclear palsy. Proc. Natl. Acad. Sci. USA 86, 2493-2497.
16. Greengard, P., Allen, P. B., & Nairn, A. C. (1999) Beyond the dopamine receptors: The DARPP-32/protein phosphatase-1 cascade. Neuron 23, 435-447.
17. Harris, K. M., & Kater, S. B. (1994) Dendritic spines: cellular specializations imparting both stability and flexibility to synaptic function. Ann. Rev. Neurosci. 17, 341-371.
18. Hemmings, H. C., Jr., Greengard, P., Tung, H. Y. L., & Cohen, P. (1984) DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature 310, 503-505.
19. Hemmings, H. C., Jr., & Greengard, P. (1986) DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein: Regional, tissue and phylogenetic distribution. J. Neurosci. 6, 1469-1481.
20. 3-calcineurin-signaling cascade. J. Neurosci. 20, 8987-8995.
21. Hersch, S. M., Ciliax, B. J., Gutekunst, C. A., Rees, H. D., Heilman, C. J., Yung, K. K., Bolam, J. P., Ince, E., Yi, H., & Levey, A. I. (1995) Electron microscopic analysis of D1 and D2 receptor proteins in the dorsal striatum and their synaptic relationships with motor cortcostriatal afferents. J. Neurosci. 15, 5222-5237.
22. Hunter, T., & Sefton, B. M. (1991) Protein Phosphorylation, Part B. In Methods in Enzymology, Vol. 201. Academic Press, San Diego.
23. Ingham, C. A., Hood, S. H., & Arbuthnott, G. W. (1989) Spine density on neostriatal neurons changes with 6-hydroxydopamine lesions and with age. Brain Res. 503, 334-338.
24. Kaibuchi, K. (1999) Regulation of cytoskeleton and cell adhesion by Rho targets. Prog. Mol. Subcell. Biol. 22, 23-38.
25. Kaur, S., & Starr, M. S. (1997) Differential effects of intrastriatal and intranigral injections of glutamate antagonists on motor behaviour in the reserpine-treated rat. Neuroscience 76, 345-354.
26. Klockgether, T., & Turski, L. (1990) NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats. Ann. Neurol. 28, 539-546.
27. Koetter, R. (1994) Postsynaptic integration of glutamatergic and dopaminergic signals in the striatum. Prog. Neurobiol. 44, 163-196.
28. 4, receptors in the striatum without the involvement of action potentials. J. Neurosci. 20, 6666-6671.
29. Luthman, J., Linqvist, E., Young, D., & Cowburn, R. (1990) Neonatal dopamine lesion in the rat results in enhanced adenylate cyclase activity without altering dopamine receptor binding or dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein (DARPP-32) immunoreactivity. Exp. Brain Res. 83, 85-95.
30. McNeill, T. H., Brown, S. A., Rafols, J. A., & Shoulson, I. (1988) Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease. Brain Res. 445, 148-152.
31. Menegoz, M., Iau, L. F., Hervé, D., Huganir, R. L., & Girault, J. A. (1996) Tyrosine phosphorylation of NMDA receptor in rat striatum: Effects of 6-OH-dopamine lesions. NeuroReport 7, 125-128.
32. Morelli, M., Fenu., S., Pinna, A., & Di Chiara, G. (1992) Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behavior in the 6-hydroxydopamine model of turning: Relationship with c-fos expression. J. Pharmacol. Exp. Ther. 260, 402-408.
33. Nishi, A., Snyder, G. L., & Greengard, P. (1997) Bidirectional regulation of DARPP-32 phosphorylation by dopamine. J. Neurosci. 17, 8147-8155.
34. Nishi, A., Bibb, J. A., Snyder, G. L., Higashi, H., Nairn, A. C., & Greengard, P. (2000) Amplification of dopaminergic signaling by a positive feedback loop Proc. Natl. Acad. Sci. USA 97, 12840-12845.
35. Nitsch, C., & Riesenberg, R. (1995) Synaptic reorganisation after dopamine deafferentation: An ultrastructural study using glutamate decarboxylase immunocytochemistry. Synapse 19, 247-263.
36. Oh, J. D., Russel, D., Vaughan, C. L., & Chase, T. N. (1998) Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: Effect of dopaminergic denervation and L-DOPA administration. Brain Res. 813, 150-159.
37. Papa, S. M., Engber, T. M., Boldry, R. C., & Chase, T. N. (1993) Opposite effects of NMDA and AMPA receptor blockade on catalepsy induced by dopamine receptor antagonists. Eur. J. Pharmacol. 232, 247-253.
38. Paul, S., Snyder, G. L., Yokakura, H., Picciotto, M. R., Nairn, A. C., & Lombroso, P. J. (2000) The dopamine/D1 receptor mediates the phosphorylation and inactivation of the protein tyrosine phosphatase STEP via a PKA-dependent pathway. J. Neurosci. 20, 5630-5638.
39. Paxinos, G., & Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney.
40. Raisman-Vozari, R., Girault, J. A., Moussaoui, S., Feuerstein, C., Jenner, P., Marsden, C. D., & Agid, Y. (1990) Lack of change in striatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in man. Brain Res. 507, 45-50.
41. Schwarting, R. K. W., & Huston, J. P. (1996) Unilateral 6-hydroxydopamine lesions of mesostriatal dopamine neurons and their physiological sequelae. Prog. Neurobiol. 49, 215-266.
42. Starr, M. S. (1995) Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease. Synapse 19, 264-293.
43. Stoof, J. C., & Kebabian, J. W. (1981) Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 294, 366-368.
44. Tang, K. C., Low, M. J., Grandy, D. K., & Lovinger, D. M. (2001) Dopamine-dependent synaptic plasticity in striatum during in vivo development. Proc. Natl. Acad. Sci. USA 98, 1255-1260.
45. Ulas, J., & Cotman, C. W. (1996) Dopaminergic denervation of striatum results in elevated expression of NR2A subunit. NeuroReport 7, 1789-1793.
46. 2 dopamine receptors induce mitogen-activated protein kinase and cAMP response element-binding protein phosphorylation in neurons. Proc. Natl. Acad. Sci. USA 96, 11607-11612.